CSIMarket Company Name, Ticker, Industry, else..


Organon and Co   (NYSE: OGN)
Other Ticker:  
 

Organon and Co

OGN's Fundamental analysis



Looking into Organon And Co growth rates, revenue grew by 4.15 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1766

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Organon And Co 's net income grew by 518.97 % in III. Quarter 2024 year on year, above company average,

• More on OGN's Growth


Organon And Co
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Organon And Co PEG ratio is at 0.03 Company is currently trading with Price to Cash flow multiple of 11.89 in trailing twelve-month period.
Company
3.18
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.65.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.23.


• More on OGN's Valuation
 
 Total Debt (Millions $) 8,749
 Dividend TTM ($) 1.15 $
 Dividend Yield TTM (%) 7.14 %
 Revenue/Employee (TTM) $ 640,900
 Net Income/Employee (TTM) $ 130,100
 Receivable Turnover (TTM) 3.89
 Tangible Book Value (Per Share $) -18.76

Organon And Co
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Organon And Co PEG ratio is at 0.03 Company is currently trading with Price to Cash flow multiple of 11.89 in trailing twelve-month period.
Company
3.18
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.65.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.23.

Organon And Co Price to Book Ratio is at 8.41 lower than Industry Avg. of 68.99. and higher than S&P 500 Avg. of 0.01

• More on OGN's Valuation

•  Market Capitalization (Millions $) 4,148
•  Shares Outstanding (Millions) 260
•  Employees 10,000
•  Revenues (TTM) (Millions $) 6,409
•  Net Income (TTM) (Millions $) 1,301
•  Cash Flow (TTM) (Millions $) 349
•  Capital Exp. (TTM) (Millions $) -274
•  Total Debt (Millions $) 8,749
•  Dividend TTM ($) 1.15 $
•  Dividend Yield TTM (%) 7.14 %
•  Revenue/Employee (TTM) $ 640,900
•  Net Income/Employee(TTM) $ 130,100
•  Receivable Turnover Ratio (TTM) 3.89
•  Tangible Book Value (Per Share $) -18.76

•  Market Capitalization (Millions $) 4,148
•  Shares Outstanding (Millions) 260
•  Employees 10,000
•  Revenues (TTM) (Millions $) 6,409
•  Net Income (TTM) (Millions $) 1,301
•  Cash Flow (TTM) (Millions $) 349
•  Capital Exp. (TTM) (Millions $) -274


    OGN's Profitability Comparisons
Organon And Co faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 21.43 % from 23.09 % in II. Quarter.

Organon And Co net profit margin of 22.69 % is currently ranking no. 24 in Major Pharmaceutical Preparations industry, ranking no. 44 in Healthcare sector and number 612 in S&P 500.


Profitability by Segment
Total 22.69 %



  Ratio
•   Capital Ratio (MRQ) 1.7
•  Total Debt to Equity (MRQ) 17.75
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.52
•  Inventory Turnover Ratio (TTM) 2.04



Organon And Co faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 21.43 % from 23.09 % in II. Quarter.

Organon And Co net profit margin of 22.69 % is currently ranking no. 24 in Major Pharmaceutical Preparations industry, ranking no. 44 in Healthcare sector and number 612 in S&P 500.

• More on OGN's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com